Introduction
============

Venous thromboembolism (VTE) is a major cardiovascular disease.^[@b1]--[@b6]^ A number of inherited and acquired risk factors for VTE have been described.^[@b1]--[@b6]^ These include advancing age, malignancy, pregnancy, oral contraceptive use, hormone replacement therapy, surgery, immobilization, obesity, and inherited thrombophilia. Varicose veins (VVs) have also been indicated as risk factor for VTE.^[@b7]--[@b8]^

Family studies have shown that susceptibility to VTE has a heritable basis, with familial risks of ≈2 to 3.^[@b9]--[@b19]^ Several genetic risk factors have been implicated in the familial aggregation of VTE (familial thrombophilia), the 5 strongest of which are factor V Leiden (rs6025), prothrombin G20210A (rs1799963), and deficiencies of the natural anticoagulants antithrombin, protein C, and protein S.^[@b1],[@b12]^ VVs have also been shown to aggregate in families.^[@b20]--[@b25]^ No genomewide association study has yet been performed in patients with VVs. In a candidate gene study, however, a mutation in the thrombomodulin gene promoter was associated with VVs.^[@b26]^ An increased prevalence of familial thrombophilia among patients with VVs or venous ulcers has also been suggested.^[@b27]--[@b31]^ Familial thrombophilia has also been associated with superficial thrombophlebitis (thrombosis of the superficial veins).^[@b32]--[@b33]^ Consequently, a number of links exist between VVs and familial thrombophilia; however, whether family history of VVs is a risk factor for VTE has not been determined. In addition, the risk of VVs in patients with a family history of VTE has not been determined. Familial aggregation is necessary, but not sufficient, to infer a genetic cause.^[@b34]--[@b35]^ Both genetic and nongenetic factors might contribute to increased familial aggregation.^[@b34]--[@b35]^

The aim of the present study was to determine whether VVs and VTE share familial susceptibility. We hypothesized that familial aggregation of VVs is associated with VTE and that family history of VTE might promote VVs. In a nationwide family study, familial risk of VVs and VTE was analyzed in 2 ways (ie, bidirectionally): risk of VTE in subjects whose siblings had been diagnosed with VVs and risk of VVs in subjects whose siblings had been diagnosed with VTE. To investigate the contribution of adult shared family environment, spouses\' risks were assessed.

Methods
=======

This study was approved by the ethics committee of Lund University, Sweden. Data used in this study represented information on all persons registered as residents of Sweden. It included individual‐level information on age, sex, education, siblings, spouses, socioeconomic status (occupation), geographic region of residence, hospital and outpatient diagnoses, dates of hospital admissions (1964--2008), date of emigration, and date and cause of death. The data sources comprised several national Swedish registers, including the Swedish National Population and Housing Census (1960--1990), the Total Population Register, the Immigration Register, the Multigeneration Register, the Swedish Hospital Discharge Register (1964--2008), and the Outpatient Register (2001--2008), provided to us by Statistics Sweden (a Swedish government--owned statistics bureau) and the National Board of Health and Welfare.^[@b14]--[@b19],[@b36]--[@b39]^

Statistics Sweden provided the Multigeneration Register, in which persons born in Sweden since 1932 are linked to their siblings. Data were linked to national census data to retrieve information relating to individual‐level socioeconomic status and, finally, to data from the Swedish Hospital Discharge Register and Outpatient Register. Data linkage was performed using the personal identification numbers that are assigned to all residents in Sweden for their lifetimes. For each person, this number was replaced by a serial number to maintain anonymity. The serial number was used to check that each person was entered only once for his or her first VTE or VV diagnosis (as a cause of hospitalization). The follow‐up time ran from January 1, 1964, until December 31, 2008.

Data in the Swedish registers are remarkably complete. In 2001, personal identification numbers were missing for only 0.4% of hospitalizations, and main diagnosis was missing for 0.9% of hospitalizations.^[@b37]^ Information on occupational status, retrieved from national census records, was 99.2% complete.^[@b37]^ The Swedish Hospital Discharge Register was started in 1964 and has had nationwide coverage since 1987. It boasts nearly 90% overall validity.^[@b36],[@b38]--[@b39]^ Validity for specific cardiovascular disorders such as VTE, myocardial infarction, and stroke is even higher (around 95%).^[@b36],[@b38]--[@b41]^

Outcome Variable
----------------

Patients with VTE and VVs, classified according to different revisions of the World Health Organization International Classification of Diseases (ICD; ICD‐7 before 1968, ICD‐8 from 1968 to 1986, ICD‐9 from 1987 to 1996, and ICD‐10 from 1997 onward), were identified in the Hospital Discharge Register and the Outpatient Register. Only main diagnoses of VTE and VVs were considered to ensure high validity. VTE was defined by the following ICD codes, as previously described:^[@b14]--[@b19]^ 463, 464, 465, 466, 583.00, 334.40, 334.50, 682, and 684 (ICD‐7); 450, 451, 452, 453, 671, and 673.9 (ICD‐8); 437G, 451, 452, 453, 415B, 416W, 671C, 671D, 671E, 671F, 671X, 673C, and 639G (ICD‐9); and I26, I636, I676, I80, I81, I82, O222, O223, O225, O228, O229, O870, O871, O873, O879, O882, O082, and O087 (ICD‐10). VTE was further subjected to subanalyses of venous thrombosis of the legs, pulmonary embolism, and other forms of venous thromboembolism ([Table 1](#tbl01){ref-type="table"}).

###### 

ICD Codes for the Different Subtypes of VTE

         ICD‐7                                              ICD‐8        ICD‐9                         ICD‐10
  ------ -------------------------------------------------- ------------ ----------------------------- -----------------------------------------------------
  VT     463, 682.00                                        451, 671     451, 671C, 671D, 671E, 671X   I80, O222, O223, O228, O229, O870, O871, O879, O087
  PE     405, 684                                           450, 673.9   415B, 416W, 673C, 639G        I26, O882, O082
  OVTE   334.40, 334.50, 464, 466, 583.00, 682.10, 682.99   452, 453     452, 453, 437G, 671F          I81, I82, I636, I676, O225, O873

ICD indicates International Classification of Diseases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; VT, venous thrombosis of the legs.

VVs were defined by the following ICD codes:^[@b25]^ 460 (ICD‐7), 454 (ICD‐8), 454 and 671A (ICD‐9), and I83 and O220 (ICD‐10). Individuals diagnosed with VVs during the follow‐up period were identified based on their first recorded diagnosis in the Hospital Discharge Register or Outpatient Register. Uncomplicated VVs (no inflammation or ulceration) were defined by the following ICD codes: 460.00 and 460.10 (ICD‐7), 454.99 (ICD‐8), 454X and 671A (ICD‐9), and I83.9 and O22.0 (varicose veins during pregnancy) (ICD‐10). Complicated varicose veins (with ulceration and/or inflammation) were defined by the following ICD codes: 460.20 (varicose veins with ulcer) (ICD‐7); 454.00 (varicose veins with ulcer (ICD‐8); 454A (varicose veins with ulcer), 454B (varicose veins with inflammation), and 454C (varicose veins with ulcer and inflammation) (ICD‐9); and I83.0 (varicose veins with ulcer), I83.1 (varicose veins with inflammation), and I83.2 (varicose veins with ulcer and inflammation) (ICD‐10).

Predictor Variable
------------------

The predictor variable was diagnosis of VTE or VVs during the study period (1964--2008) for a sibling, namely, a sibling history of VTE or VVs, respectively. To analyze the effect of shared household in adulthood, the risk of VTE or VVs in spouses were analyzed in those with a spouse affected by VVs or VTE, respectively. Spouses were defined on the basis of common children born 1932 or later.

Adjustment Variables
--------------------

Adjustments were made for sex, age, time period, socioeconomic status, and geographic region of residence. Sex was male or female. Age was age at diagnosis (5‐year age group categories). Time period was the time divided into 4 different follow‐up periods (1965--1974, 1975--1984, 1985--1994, and 1995--2008). Socioeconomic status was assessed in terms of occupation, divided into 6 groups according to the Swedish socioeconomic classification of Statistics Sweden: farmer, blue‐collar worker, manual worker, professional, private, and others (economically inactive individuals, including unemployed individuals and homemakers). Geographic region of residence was included to adjust for possible regional differences in admissions. It was categorized as "large city," "southern Sweden," and "northern Sweden." Large cities were defined as cities with a population of \>200 000 and comprised the 3 largest cities in Sweden: Stockholm, Gothenburg, and Malmö.

Statistical Analysis
--------------------

Familial risks were analyzed, as described previously.^[@b14]--[@b18],[@b25],[@b42]^ Person‐years at risk (ie, number of persons at risk multiplied by the time at risk) were calculated from the start of follow‐up (January 1, 1964) until hospitalization for VTE or VVs, death, emigration, or the end of the follow‐up (December 31, 2008).^[@b43]^ Age‐adjusted incidence rates were calculated for the whole follow‐up period, divided into 5‐year periods.^[@b14]--[@b18],[@b25]^ Standardized incidence ratios (SIRs) were used to measure the relative risk of VTE in persons with a sibling history of VVs (hospitalization or death) compared with those without a sibling history of VTE. Similar calculations were performed separately for spouses.

Familial SIRs were calculated as the ratio of observed (*O*) and expected (*E*) numbers of VTE or VV cases using the indirect standardization method:^[@b43]^In this method, *O*=∑*O*~*j*~ denotes the total number of observed cases in the study group; *E*\* (expected number of cases) is calculated by applying stratum‐specific standardized incidence rates () obtained from the reference group to the stratum‐specific person‐years of risk (*n*~*j*~) for the study group; *O*~*j*~ represents the observed number of cases that the cohort subjects contribute to the *j*th stratum; and *J* represents the strata defined by cross‐classification of the following adjustment variables: age (5‐year groups), sex, socioeconomic status, time period, and geographic region of residence.^[@b43]^ The 95% CIs were calculated assuming a Poisson distribution.^[@b43]^

Cause‐specific and overall mortality hazard ratios (HRs) were calculated using Cox regression.

Data are accurate to 2 decimals places. All analyses were performed using SAS version 9.2 (SAS Institute).

Results
=======

Baseline characteristics for individuals included in the sibling analysis are presented in [Table 2](#tbl02){ref-type="table"}. A total of 87 564 patients were diagnosed with VTE ([Table 2](#tbl02){ref-type="table"}). The median age was 51 years. A total of 96 810 patients were diagnosed with VVs ([Table 2](#tbl02){ref-type="table"}). The median age was 46 years. In [Table 3](#tbl03){ref-type="table"} baseline characteristics are presented for those included in the spouse analysis.

###### 

Basic Characteristics in Patients With VVs and VTE

  Basic Characteristics   VVs      VTE              
  ----------------------- -------- ------- -------- -------
  Sex                                               
  Male                    28 336   29.3    41 456   47.3
  Female                  68 474   70.7    46 108   52.7
  Age, y                                            
  \<30                    7232     7.5     10 599   12.1
  30 to 39                22 835   23.6    13 123   15.0
  40 to 49                26 046   26.9    17 496   20.0
  ≥50                     40 697   42.0    46 346   52.9
  Median, y               46               51       
  Time period                                       
  1965--1974              4467     4.6     949      1.1
  1975--1984              13 139   13.6    5218     6.0
  1985--1994              15 136   15.6    15 328   17.5
  1995--2008              64 068   66.2    66 069   75.5
  Socioeconomic status                              
  Farmer                  1395     1.4     1286     1.5
  Manual worker           39 620   40.9    30 548   34.9
  Blue collar             27 276   28.2    22 660   25.9
  Professional            6697     6.9     7536     8.6
  Private                 3419     3.5     3171     3.6
  Others                  18 403   19.0    22 363   25.5
  Region                                            
  Large city              31 388   32.4    33 267   38.0
  Southern Sweden         44 517   46.0    37 503   42.8
  Northern Sweden         20 286   21.0    15 851   18.1
  Unknown                 619      0.6     943      1.1
  Without sibling         14 714   15.2    14 610   16.7
  With sibling                                      
  Sibling history         4993     5.2     4929     5.7
  No history              77 103   79.6    68 025   77.6
  All                     96 810   100.0   87 564   100.0

VTE indicates venous thromboembolism; VVs, varicose veins.

###### 

Basic Characteristics Among Spouses With VVs and VTE

  Basic Characteristics   VVs       VTE               
  ----------------------- --------- ------- --------- -------
  Sex                                                 
  Male                    54 906    29.3    104 489   46.82
  Female                  132 480   70.7    118 670   53.18
  Age, y                                              
  \<30                    6222      3.32    6889      3.09
  30 to 39                26 164    13.96   12 149    5.44
  40 to 49                38 806    20.71   19 315    8.66
  ≥50                     116 194   62.01   184 806   82.81
  Median, y               54                68        
  Period                                              
  1965--1974              28 461    15.19   7317      3.28
  1975--1984              42 783    22.83   33 630    15.07
  1985--1994              32 568    17.38   60 414    27.07
  1995--2008              83 574    44.6    121 798   54.58
  Socioeconomic status                                
  Farmer                  1298      0.69    2264      1.01
  Manual worker           48 597    25.93   62 348    27.94
  Blue collar             41 410    22.1    57 270    25.66
  Professional            13 828    7.38    21 114    9.46
  Private                 4353      2.32    6686      3
  Others                  77 900    41.57   73 477    32.93
  Region                                              
  Large city              63 795    34.04   82 437    36.94
  Southern Sweden         71 554    38.19   86 925    38.95
  Northern Sweden         31 964    17.06   35 481    15.9
  Unknown                 20 073    10.71   18 316    8.21
  Sibling history                                     
  Yes                     7596      4.1     7578      3.4
  No                      179 790   95.9    215 581   96.6
  All                     187 386   100.0   223 159   100.0

VTE indicates venous thromboembolism; VVs, varicose veins.

Shared Familial Susceptibility Among Siblings
---------------------------------------------

Subjects with a sibling with VVs had an increased risk for VTE ([Table 4](#tbl04){ref-type="table"}). The overall SIR was 1.30. The familial risk was increased for venous thrombosis of the legs (SIR 1.38), pulmonary embolism (SIR 1.18), and other forms of venous thromboembolism (SIR 1.21). Sibling history of both complicated and uncomplicated VTE was associated with an increased risk for VTE. Sibling history of complicated VVs was associated with a higher risk of VTE than sibling history of uncomplicated VVs (SIR 1.60 versus SIR 1.27).

###### 

Risk of VTE in Subjects With Siblings Diagnosed With VVs

  Disease in Siblings   VT     PE                                      OVTE           All VTE                                                                                                                                                                       
  --------------------- ------ --------------------------------------- -------------- --------- --------------------------------------- -------------- ------ --------------------------------------- -------------- ------ --------------------------------------- --------------
  Uncomplicated VVs     2443   1.35[\*](#tf4-1){ref-type="table-fn"}   1.29 to 1.40   917       1.16[\*](#tf4-1){ref-type="table-fn"}   1.08 to 1.23   879    1.18[\*](#tf4-1){ref-type="table-fn"}   1.11 to 1.26   4240   1.27[\*](#tf4-1){ref-type="table-fn"}   1.23 to 1.30
  Complicated VVs       456    1.70[\*](#tf4-1){ref-type="table-fn"}   1.55 to 1.87   166       1.40[\*](#tf4-1){ref-type="table-fn"}   1.19 to 1.63   174    1.57[\*](#tf4-1){ref-type="table-fn"}   1.35 to 1.82   796    1.60[\*](#tf4-1){ref-type="table-fn"}   1.49 to 1.72
  All VVs               2841   1.38[\*](#tf4-1){ref-type="table-fn"}   1.33 to 1.43   1062      1.18[\*](#tf4-1){ref-type="table-fn"}   1.11 to 1.25   1025   1.21[\*](#tf4-1){ref-type="table-fn"}   1.14 to 1.29   4929   1.30[\*](#tf4-1){ref-type="table-fn"}   1.26 to 1.33

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

The reverse association was also significant ([Table 5](#tbl05){ref-type="table"}). Subjects with a sibling with VTE had an increased risk for VVs. The overall SIR was 1.30, and the risk was increased for both complicated VVs (SIR 1.46) and uncomplicated VVs (SIR 1.28). Sibling histories of VT, pulmonary embolism, and other forms of venous thromboembolism were all associated with an increased risk for VVs.

###### 

Risk of VVs in Subjects With Siblings Diagnosed With VTE

  Disease in Siblings   Complicated VVs   Uncomplicated VVs                       All VVs                                                                                                                     
  --------------------- ----------------- --------------------------------------- -------------- ------ --------------------------------------- -------------- ------ --------------------------------------- --------------
  VT                    438               1.61[\*](#tf5-1){ref-type="table-fn"}   1.46 to 1.77   2548   1.38[\*](#tf5-1){ref-type="table-fn"}   1.33 to 1.43   2995   1.41[\*](#tf5-1){ref-type="table-fn"}   1.36 to 1.46
  PE                    162               1.30[\*](#tf5-1){ref-type="table-fn"}   1.11 to 1.52   975    1.18[\*](#tf5-1){ref-type="table-fn"}   1.10 to 1.25   1141   1.19[\*](#tf5-1){ref-type="table-fn"}   1.12 to 1.26
  OVTE                  167               1.45[\*](#tf5-1){ref-type="table-fn"}   1.24 to 1.69   931    1.21[\*](#tf5-1){ref-type="table-fn"}   1.13 to 1.29   1100   1.24[\*](#tf5-1){ref-type="table-fn"}   1.16 to 1.31
  All VTE               720               1.46[\*](#tf5-1){ref-type="table-fn"}   1.35 to 1.57   4258   1.28[\*](#tf5-1){ref-type="table-fn"}   1.24 to 1.32   4993   1.30[\*](#tf5-1){ref-type="table-fn"}   1.27 to 1.34

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

Familial Risks According to Age and Number of Affected Siblings
---------------------------------------------------------------

The highest risk for VTE (SIR 1.52) was observed in subjects with 2 or more siblings with VVs ([Table 6](#tbl06){ref-type="table"}). The SIR for VTE in those aged younger than 40 years was 1.32, and the SIR for VVs in those aged 40 years or older was 1.28.

###### 

Risk of VTE and VVs by Age at Diagnosis and Number of Affected Siblings

  Disease in Siblings              O      SIR                                     95% CI         O      SIR                                     95% CI
  -------------------------------- ------ --------------------------------------- -------------- ------ --------------------------------------- --------------
  Risk of varicose veins                                                                                                                        
  Age at diagnosis, y              \<40   ≥40                                                                                                   
  VTE                              2568   1.34[\*](#tf6-1){ref-type="table-fn"}   1.29 to 1.40   2425   1.26[\*](#tf6-1){ref-type="table-fn"}   1.21 to 1.31
  No. of affected siblings         1      ≥2                                                                                                    
  VTE                              4619   1.28[\*](#tf6-1){ref-type="table-fn"}   1.24 to 1.32   374    1.70[\*](#tf6-1){ref-type="table-fn"}   1.53 to 1.88
  Risk of venous thromboembolism                                                                                                                
  Age at diagnosis, y              \<40   ≥40                                                                                                   
  VVs                              1731   1.32[\*](#tf6-1){ref-type="table-fn"}   1.26 to 1.38   3198   1.28[\*](#tf6-1){ref-type="table-fn"}   1.24 to 1.33
  No. of affected siblings         1      ≥2                                                                                                    
  VVs                              4495   1.28[\*](#tf6-1){ref-type="table-fn"}   1.24 to 1.32   434    1.52[\*](#tf6-1){ref-type="table-fn"}   1.38 to 1.67

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; SIR, standardized incidence ratio; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

The highest risk for VVs (SIR 1.70) was observed in subjects with 2 or more siblings with VTE ([Table 6](#tbl06){ref-type="table"}). The SIR for VVs in those aged younger than 40 years was 1.34, and the SIR for VVs in those aged 40 years or older was 1.26.

Mortality in Patients With a Sibling History of VTE or VVs
----------------------------------------------------------

A multivariate survival analysis using Cox regression with HRs for overall death and VTE‐related death was performed ([Table 7](#tbl07){ref-type="table"}). A sibling history of VTE increased VTE cause‐specific mortality (HR 1.60, 95% CI 1.31 to 1.95) and, slightly, overall mortality (HR 1.09, 95% CI 1.07 to 1.11). Family history of VVs did not affect VTE cause‐specific mortality (HR 0.88, 95% CI 0.69 to 1.13) or overall mortality (HR 0.99, 95% CI 0.97 to 1.01).

###### 

Mortality Among Patients With VTE by Sibling History

  Siblings\' Diseases   Cause‐Specific Mortality   Overall Mortality                                                                                       
  --------------------- -------------------------- --------------------------------------- -------------- -------- --------------------------------------- --------------
  VTE                   106                        1.60[\*](#tf7-1){ref-type="table-fn"}   1.31 to 1.95   11 330   1.09[\*](#tf7-1){ref-type="table-fn"}   1.07 to 1.11
  VVs                   69                         0.88                                    0.69 to 1.13   11 829   0.99                                    0.97 to 1.01

HRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. HR indicates hazard ratio; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

Familial Risks Among Spouses
----------------------------

To investigate the contribution of shared adult family environment, spouse effects were assessed. Among spouses, only slightly increased risks were observed (Tables [8](#tbl08){ref-type="table"} and [9](#tbl09){ref-type="table"}). In spouses of VTE patients, a minor increase in risk of VVs was observed (SIR 1.05 for husbands, SIR 1.06 for wives). The risk of VTE in spouses of VV patients was similarly small (SIR 1.01 for husbands, SIR 1.05 for wives).

###### 

Risk of VVs in Subjects With Spouses Diagnosed With VTE

  Disease in Spouse    Complicated VVs   Uncomplicated VVs                       All VVs                                                                                                                     
  -------------------- ----------------- --------------------------------------- -------------- ------ --------------------------------------- -------------- ------ --------------------------------------- --------------
  Disease in husband                                                                                                                                                                                         
  VT                   308               1.02                                    0.91 to 1.14   1794   1.06[\*](#tf8-1){ref-type="table-fn"}   1.02 to 1.11   2124   1.06[\*](#tf8-1){ref-type="table-fn"}   1.01 to 1.10
  PE                   263               1.06                                    0.93 to 1.19   1282   1.03                                    0.97 to 1.09   1565   1.03                                    0.98 to 1.08
  OVTE                 236               0.99                                    0.86 to 1.12   1267   1.06[\*](#tf8-1){ref-type="table-fn"}   1.00 to 1.12   1529   1.05                                    1.00 to 1.11
  All VTE              807               1.02                                    0.95 to 1.09   4343   1.05[\*](#tf8-1){ref-type="table-fn"}   1.02 to 1.08   5218   1.05[\*](#tf8-1){ref-type="table-fn"}   1.02 to 1.08
  Disease in wife                                                                                                                                                                                            
  VT                   225               1.19[\*](#tf8-1){ref-type="table-fn"}   1.04 to 1.36   913    1.08[\*](#tf8-1){ref-type="table-fn"}   1.02 to 1.16   1148   1.10[\*](#tf8-1){ref-type="table-fn"}   1.04 to 1.17
  PE                   136               1.11                                    0.93 to 1.31   518    0.94                                    0.86 to 1.02   663    0.97                                    0.90 to 1.05
  OVTE                 96                1.01                                    0.82 to 1.24   463    1.09                                    0.99 to 1.19   568    1.08                                    0.99 to 1.17
  All VTE              457               1.13[\*](#tf8-1){ref-type="table-fn"}   1.02 to 1.23   1893   1.04                                    0.99 to 1.09   2378   1.06[\*](#tf8-1){ref-type="table-fn"}   1.02 to 1.10

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

###### 

Risk of VTE in Subjects With Spouses Diagnosed With VVs

  Disease in Spouse    VT     PE                                      OVTE           All VTE                                                                                                                                      
  -------------------- ------ --------------------------------------- -------------- --------- ------ -------------- ------ --------------------------------------- -------------- ------ --------------------------------------- --------------
  Disease in husband                                                                                                                                                                                                              
  Uncomplicated VVs    907    1.03                                    0.96 to 1.09   525       0.90   0.82 to 0.98   463    1.05                                    0.95 to 1.15   1894   0.99                                    0.95 to 1.04
  Complicated VVs      227    1.15[\*](#tf9-1){ref-type="table-fn"}   1.01 to 1.31   135       1.03   0.86 to 1.22   97     0.97                                    0.79 to 1.19   459    1.07                                    0.98 to 1.18
  All VVs              1144   1.05                                    0.99 to 1.11   669       0.93   0.86 to 1.00   569    1.04                                    0.95 to 1.13   2381   1.01                                    0.97 to 1.05
  Disease in wife                                                                                                                                                                                                                 
  Uncomplicated VVs    1786   1.06[\*](#tf9-1){ref-type="table-fn"}   1.01 to 1.11   1277      1.03   0.97 to 1.09   1258   1.07[\*](#tf9-1){ref-type="table-fn"}   1.01 to 1.13   4321   1.05[\*](#tf9-1){ref-type="table-fn"}   1.02 to 1.08
  Complicated VVs      309    1.08                                    0.96 to 1.20   263       1.08   0.95 to 1.22   236    0.97                                    0.85 to 1.11   808    1.04                                    0.97 to 1.12
  All VVs              2117   1.06[\*](#tf9-1){ref-type="table-fn"}   1.01 to 1.11   1560      1.04   0.99 to 1.09   1520   1.06[\*](#tf9-1){ref-type="table-fn"}   1.00 to 1.11   5197   1.05[\*](#tf9-1){ref-type="table-fn"}   1.02 to 1.08

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

Additional Analysis
-------------------

Stratified analysis was performed according to sex. The sex‐specific familial risks were increased for both males and females (Tables [10](#tbl10){ref-type="table"} and [11](#tbl11){ref-type="table"}). We also excluded VVs cases related to pregnancy (Tables [12](#tbl12){ref-type="table"} and [13](#tbl13){ref-type="table"}). The familial risks were similar, although a tendency for slightly higher familial risks was observed. The risk for VTE was 1.38 (95% CI 1.33 to 43) after exclusion of pregnancy‐related varicose veins.

###### 

Risk of Venous Thromboembolism When Siblings Were Diagnosed With VVs by Sex

  Siblings\' Diseases   Male   Female                                                                                                  
  --------------------- ------ ---------------------------------------- -------------- ------ ---------------------------------------- --------------
  Uncomplicated VVs     2079   1.25[\*](#tf10-1){ref-type="table-fn"}   1.2 to 1.31    2161   1.28[\*](#tf10-1){ref-type="table-fn"}   1.22 to 1.33
  Complicated VVs       399    1.61[\*](#tf10-1){ref-type="table-fn"}   1.45 to 1.77   397    1.6[\*](#tf10-1){ref-type="table-fn"}    1.44 to 1.76
  All VVs               2417   1.28[\*](#tf10-1){ref-type="table-fn"}   1.23 to 1.33   2512   1.31[\*](#tf10-1){ref-type="table-fn"}   1.26 to 1.36

SIRs are adjusted for age, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; SIR, standardized incidence ratio; VVs, varicose veins.

95% CI does not include 1.00.

###### 

Risk of Varicose Veins When Siblings Were Diagnosed With VTE by Sex

  Siblings\' Diseases   Male   Female                                                                                                  
  --------------------- ------ ---------------------------------------- -------------- ------ ---------------------------------------- --------------
  VT                    956    1.5[\*](#tf11-1){ref-type="table-fn"}    1.4 to 1.59    2039   1.37[\*](#tf11-1){ref-type="table-fn"}   1.31 to 1.43
  PE                    377    1.29[\*](#tf11-1){ref-type="table-fn"}   1.16 to 1.43   764    1.15[\*](#tf11-1){ref-type="table-fn"}   1.07 to 1.24
  OVTE                  376    1.4[\*](#tf11-1){ref-type="table-fn"}    1.26 to 1.54   724    1.17[\*](#tf11-1){ref-type="table-fn"}   1.08 to 1.25
  All VTE               1614   1.39[\*](#tf11-1){ref-type="table-fn"}   1.33 to 1.46   3379   1.26[\*](#tf11-1){ref-type="table-fn"}   1.22 to 1.31

SIRs are adjusted for age, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism.

95% CI does not include 1.00.

###### 

Risk of VVs When Siblings Were Diagnosed With VTE Excluding Pregnancy‐Related VVs

  Siblings\' Diseases   VVs                                             
  --------------------- ------ ---------------------------------------- --------------
  VT                    1734   1.53[\*](#tf12-1){ref-type="table-fn"}   1.46 to 1.60
  PE                    682    1.30[\*](#tf12-1){ref-type="table-fn"}   1.20 to 1.40
  OVTE                  634    1.31[\*](#tf12-1){ref-type="table-fn"}   1.21 to 1.41
  All VTE               2885   1.40[\*](#tf12-1){ref-type="table-fn"}   1.35 to 1.45

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

###### 

Risk of VTE When the Siblings Were Diagnosed With VVs Excluding Pregnancy‐Related VVs

  Siblings\' Diseases   All VTE                                            
  --------------------- --------- ---------------------------------------- --------------
  Uncomplicated VVs     2095      1.32[\*](#tf13-1){ref-type="table-fn"}   1.26 to 1.38
  Complicated VVs       903       1.61[\*](#tf13-1){ref-type="table-fn"}   1.51 to 1.72
  All VVs               2929      1.38[\*](#tf13-1){ref-type="table-fn"}   1.33 to 1.43

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; SIR, standardized incidence ratio; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

Stratified analysis was also done according to country of birth, which did not change the results compared with Swedish‐born individuals (Tables [14](#tbl14){ref-type="table"} and [15](#tbl15){ref-type="table"}). A similar tendency for increased familial risks was noted for immigrants born in Europe as well as for those born in countries outside Europe; however, there were few familial cases, and most familial risks were not significant (Tables [14](#tbl14){ref-type="table"} and [15](#tbl15){ref-type="table"}).

###### 

Risk of Venous Thromboembolism When Siblings Were Diagnosed With VVs by Country of Birth

  Siblings\' Diseases   Sweden   European                                 Others                                                                                  
  --------------------- -------- ---------------------------------------- -------------- ---- ------ -------------- ---- ---------------------------------------- --------------
  Uncomplicated VVs     4157     1.26[\*](#tf14-1){ref-type="table-fn"}   1.23 to 1.30   70   1.27   0.99 to 1.61   13   2.25[\*](#tf14-1){ref-type="table-fn"}   1.19 to 3.86
  Complicated VVs       786      1.61[\*](#tf14-1){ref-type="table-fn"}   1.50 to 1.73   9    1.15   0.52 to 2.19   1    1.42                                     0.00 to 8.14
  All VVs               4837     1.30[\*](#tf14-1){ref-type="table-fn"}   1.26 to 1.33   78   1.25   0.99 to 1.57   14   2.18[\*](#tf14-1){ref-type="table-fn"}   1.19 to 3.67

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; SIR, standardized incidence ratio; VVs, varicose veins.

95% CI does not include 1.00.

###### 

Risk of Varicose Veins When Siblings Were Diagnosed With VTE by Country of Birth

  Siblings\' Diseases   Sweden   European                                 Others                                                
  --------------------- -------- ---------------------------------------- -------------- ---- ------ -------------- ---- ------ --------------
  VTE                   2944     1.42[\*](#tf15-1){ref-type="table-fn"}   1.37 to 1.47   45   1.15   0.84 to 1.54   6    1.12   0.40 to 2.46
  PE                    1119     1.19[\*](#tf15-1){ref-type="table-fn"}   1.12 to 1.27   19   1.12   0.68 to 1.76   3    1.52   0.29 to 4.51
  OVTE                  1080     1.24[\*](#tf15-1){ref-type="table-fn"}   1.17 to 1.31   18   1.11   0.66 to 1.76   2    0.97   0.09 to 3.58
  All VTE               4905     1.31[\*](#tf15-1){ref-type="table-fn"}   1.27 to 1.34   77   1.10   0.87 to 1.38   11   1.20   0.60 to 2.16

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VTE, venous thromboembolism.

95% CI does not include 1.00.

Sensitivity Analysis
--------------------

We included only main diagnoses because the validity is generally higher for main diagnoses in the Swedish Hospital Discharge Register. A sensitivity analysis with inclusion of both main and secondary diagnoses gave similar results (Tables [16](#tbl16){ref-type="table"} and [17](#tbl17){ref-type="table"}).

###### 

Risk of VVs When Siblings Were Diagnosed With VTE Using Main and Secondary Diagnosis

  Siblings\' Diseases   VVs                                             
  --------------------- ------ ---------------------------------------- --------------
  VT                    3550   1.4[\*](#tf16-1){ref-type="table-fn"}    1.36 to 1.45
  PE                    1356   1.14[\*](#tf16-1){ref-type="table-fn"}   1.08 to 1.2
  OVTE                  1349   1.22[\*](#tf16-1){ref-type="table-fn"}   1.16 to 1.29
  All VTE               5950   1.28[\*](#tf16-1){ref-type="table-fn"}   1.25 to 1.31

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

###### 

Risk of VTE When Siblings Were Diagnosed With VVs Using Main and Secondary Diagnosis

  Siblings\' Diseases   All VTE                                            
  --------------------- --------- ---------------------------------------- --------------
  Uncomplicated VVs     5035      1.25[\*](#tf17-1){ref-type="table-fn"}   1.21 to 1.28
  Complicated VVs       981       1.54[\*](#tf17-1){ref-type="table-fn"}   1.44 to 1.63
  All VVs               5887      1.27[\*](#tf17-1){ref-type="table-fn"}   1.24 to 1.31

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; SIR, standardized incidence ratio; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

The outpatient register is available only from 2001. A sensitivity analysis showed that the familial risks were increased in the periods 1964--2000 and 2001--2008 (Tables [18](#tbl18){ref-type="table"} and [19](#tbl19){ref-type="table"}). The results were not different to any major degree.

###### 

Risk of Venous Thromboembolism When Siblings Were Diagnosed With VVs by Year of Diagnosis

  Siblings\' Diseases   \<2000   2001 or Later                                                                                           
  --------------------- -------- ---------------------------------------- -------------- ------ ---------------------------------------- --------------
  Uncomplicated VVs     1790     1.24[\*](#tf18-1){ref-type="table-fn"}   1.18 to 1.30   2450   1.30[\*](#tf18-1){ref-type="table-fn"}   1.25 to 1.35
  Complicated VVs       356      1.64[\*](#tf18-1){ref-type="table-fn"}   1.48 to 1.82   440    1.59[\*](#tf18-1){ref-type="table-fn"}   1.45 to 1.75
  All VVs               2089     1.27[\*](#tf18-1){ref-type="table-fn"}   1.22 to 1.33   2840   1.33[\*](#tf18-1){ref-type="table-fn"}   1.28 to 1.38

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; SIR, standardized incidence ratio; VVs, varicose veins.

95% CI does not include 1.00.

###### 

Risk of Varicose Veins When Siblings Were Diagnosed With VTE by Year of Diagnosis

  Siblings\' Diseases   \<2000   2001 or Later                                                                                           
  --------------------- -------- ---------------------------------------- -------------- ------ ---------------------------------------- --------------
  VT                    1373     1.51[\*](#tf19-1){ref-type="table-fn"}   1.43 to 1.59   1622   1.38[\*](#tf19-1){ref-type="table-fn"}   1.31 to 1.44
  PE                    549      1.30[\*](#tf19-1){ref-type="table-fn"}   1.19 to 1.41   592    1.15[\*](#tf19-1){ref-type="table-fn"}   1.06 to 1.25
  OVTE                  509      1.31[\*](#tf19-1){ref-type="table-fn"}   1.19 to 1.42   591    1.22[\*](#tf19-1){ref-type="table-fn"}   1.13 to 1.33
  All VTE               2300     1.39[\*](#tf19-1){ref-type="table-fn"}   1.33 to 1.44   2693   1.28[\*](#tf19-1){ref-type="table-fn"}   1.23 to 1.33

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism.

95% CI does not include 1.00.

In the sibling analysis, all persons were included, even those without a sibling. Consequently, we performed a sensitivity analysis with exclusion of those who had no sibling. The familial risks, however, were very similar (Tables [20](#tbl20){ref-type="table"} and [21](#tbl21){ref-type="table"}).

###### 

Risk of VVs When the Siblings Were Diagnosed With VTE Excluding Those Without Siblings

  Siblings\' Diseases   VVs                                             
  --------------------- ------ ---------------------------------------- --------------
  VT                    2995   1.40[\*](#tf20-1){ref-type="table-fn"}   1.35 to 1.45
  PE                    1141   1.18[\*](#tf20-1){ref-type="table-fn"}   1.12 to 1.25
  OVTE                  1100   1.23[\*](#tf20-1){ref-type="table-fn"}   1.15 to 1.30
  All VTE               4993   1.29[\*](#tf20-1){ref-type="table-fn"}   1.26 to 1.33

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; OVTE, other forms of venous thromboembolism; PE, pulmonary embolism; SIR, standardized incidence ratio; VT, venous thrombosis of the legs; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

###### 

Risk of VTE When Siblings Were Diagnosed With VVs Excluding Those Without Siblings

  Siblings\' Diseases   All VTE                                            
  --------------------- --------- ---------------------------------------- --------------
  Uncomplicated VVs     4240      1.27[\*](#tf21-1){ref-type="table-fn"}   1.23 to 1.31
  Complicated VVs       796       1.61[\*](#tf21-1){ref-type="table-fn"}   1.50 to 1.73
  All VVs               4929      1.30[\*](#tf21-1){ref-type="table-fn"}   1.27 to 1.34

SIRs are adjusted for age, sex, time period, geographic region of residence, and socioeconomic status. O indicates observed number of cases; SIR, standardized incidence ratio; VTE, venous thromboembolism; VVs, varicose veins.

95% CI does not include 1.00.

Discussion
==========

To our knowledge, this is the first nationwide study to assess the familial risk of VTE in relation to VVs. The associations we found between VVs and VTE show that VVs and VTE share familial susceptibility. The low spousal risks suggest only a minor contribution of nongenetic shared environmental factors in adults.^[@b36]^ The higher familial risk for those with 2 affected siblings also suggests that genetic factors might be involved in the sharing of familial susceptibility by VTE and VVs. Consequently, the observed increase in the risk of VTE in patients with VVs might have not only a familial background but possibly also a genetic background.^[@b7]--[@b8]^

Mutations associated with thrombophilia have been linked to VVs accompanied by chronic leg ulcers^[@b27]--[@b30]^; however, only one small study of 27 patients with VVs has investigated the possible association between thrombophilic mutations and VVs without chronic leg ulcers.^[@b30]^ Another study found an association between a mutation in thrombomodulin and VVs, but no association of the same mutation with VTE was found.^[@b26]^ The results of the present study are in harmony with those studies that found an association between familial thrombophilia and chronic leg ulcers^[@b27]--[@b30]^ and suggests the need for larger studies of the importance of thrombophilic mutations in patients with chronic leg ulcers. It is also possible that unknown vessel wall‐related genetic risk factors for VVs might be risk factors for VTE. It is worth highlighting the association between VVs and not only VT but also pulmonary embolism and thrombosis at sites other than the legs and lungs (Tables [4](#tbl04){ref-type="table"} and [5](#tbl05){ref-type="table"}).

Family history of VTE in the Swedish population is a relatively specific risk factor for venous disorders (ie, VTE and VVs).^[@b14]--[@b19],[@b25],[@b36],[@b44]^ We found weak or no associations, for example, between family history of VTE and risk for coronary heart disease or myocardial infarction, ischemic stroke, cancer, and pre‐eclampsia or eclampsia in the Swedish population.^[@b45]--[@b48]^ In contrast, venous thrombosis of the legs and pulmonary embolism share familial susceptibility not only with each other but also with rare forms of VTE. In Sweden, the major familial causes of venous disease are clearly different from the major familial causes of coronary heart disease or myocardial infarction, ischemic stroke, cancer, and pre‐eclampsia or eclampsia.

The present study has a number of strengths. These include nationwide coverage in a country with high medical standards and diagnosis of patients by specialists during extended examinations in clinics.^[@b36]^ In addition, the results were not affected by recall bias because the analyses were based exclusively on diagnosed cases. Importantly, the Multigeneration Register is a validated data source that has been proven to be reliable in the study of many familial diseases.^[@b14]--[@b19],[@b25],[@b36]--[@b37],[@b49]^ Data in the data set are almost 100% complete. The study design has been successfully used in a number of studies to determine familial risks for complex diseases, including VTE and VVs.^[@b14]--[@b19],[@b25],[@b36]^

The present study also has a number of limitations. Although it covers the 45‐year period between 1964 and 2008, the Swedish Hospital Discharge Register contains complete data for only the period since 1987; therefore, events that occurred before 1964 and some events that occurred between 1964 and 1986 are missing. This probably created a nondifferential bias regarding familial risks estimates. Another potential limitation is our lack of information on the methods used to diagnose patients; however, the Swedish Hospital Discharge Register has high validity, especially for cardiovascular disorders such as VTE, stroke, and myocardial infarction (≈95%).^[@b36]--[@b41]^ Moreover, only cases in which the main diagnosis was VVs or VTE were analyzed to ensure that the analyses were of high quality. A further limitation is that outpatient data were available only for 2001--2008, which may have caused a nondifferential bias; however, subanalyses for the periods 1964--2000 and 2001--2008 showed similar risks (Tables [18](#tbl18){ref-type="table"} and [19](#tbl19){ref-type="table"}). Moreover, incidence rates were calculated for the whole follow‐up period, divided into 5‐year periods, and adjustments were made for possible changes in incidence rate over time. Another possible limitation is that we had no data for risk factors for VTE or VVs. As a compromise, we adjusted the models for socioeconomic status (occupation). Moreover, family history is a risk factor for VTE, even in the presence of provoking risk factors like surgery, injury, pregnancy, and oral contraceptive use.^[@b12]^

An important limitation is that VVs and VTE may occur in the absence of symptoms. In the present study, we focused on the first symptomatic manifestation of VV or VTE. If many cases without these conditions actually have undiagnosed VVs or VTE, this could bias the familial risks. Some selective factors may have resulted in the increased rates of VVs or VTE to favor relatives; for instance, if a relative is treated successfully, this may encourage their spouse or sibling to seek similar medical advice. Affordability of health care and the likelihood of seeking medical advice are probably not limiting factors in Sweden because all residents have equal access to almost free health care. The low spousal risk suggests that selection bias for health care seeking in certain families is not a major problem.

Although the present study was limited to Sweden, stratified analysis of familial risks in siblings of persons born outside Sweden gave similar estimates, although the confidence interval was wide due to limited numbers of cases (Tables [14](#tbl14){ref-type="table"} and [15](#tbl15){ref-type="table"}). This suggests that similar findings might be expected in other populations. The Swedish population is, for instance, genetically closely related to German and British people, and the results from Swedish nationwide family studies are likely to be valid for many persons of white origin in Europe and the United States.^[@b36],[@b50]--[@b51]^ Generalizability to other countries remains to be determined.

The results of the present study show that VTE and VVs share familial susceptibility. In some families, the familial aggregation of these disorders is relatively strong, and this, together with the low risks among spouses, suggests that VVs and VTE share familial susceptibility and possibly genetic factors.
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